The Alberta government says it will provide up to $81.2 million to four groups developing and manufacturing vaccines in the province.
Premier Jason Kenney says the money will address a need for vaccines that fight viruses such as COVID-19 and also support the broader pharmaceutical and life sciences sector.
The University of Alberta, Entos Pharmaceuticals, Applied Pharmaceutical Innovation and Northern RNA are the recipients.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.
Kenney says more than half of the money will go to the U of A’s Li Ka Shing Institute of Virology.
- Alberta family faces ‘uncertain future’ after toddler’s rare disease care funding denied
- U.S. CDC study on COVID-19 vaccine efficacy won’t be released: officials
- The U.K. just banned smoking for life for youth. Should Canada do the same?
- Eligibility age for free breast cancer screening being lowered in Alberta
-
![]()
‘Smoke-free generation’: U.K. bans people born after 2008 from purchasing cigarettes -
![]()
Alberta to cover some IVF treatments for cancer patients -
![]()
The Sheepdogs’ Ryan Gullen shares a deeply personal story on life and loss -
![]()
N.B. provides extra-mural support for special care homes to reduce healthcare strain
He notes a portion of the provincial grants will be contingent on the groups securing financial support from the federal government.
Kenney says the funding will also help to diversify Alberta’s economy.
Comments
Want to discuss? Please read our Commenting Policy first.